Cargando…
Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients
SIMPLE SUMMARY: Sarcomas are a heterogeneous group of diagnostically complex tumors with a poor prognosis and limited number of therapy options. Molecular profiling can aid pathological classification by detection of diagnostic biomarkers, and identify therapeutic opportunities for biomarker-based t...
Autores principales: | Schipper, Luuk J., Monkhorst, Kim, Samsom, Kris G., Bosch, Linda J.W., Snaebjornsson, Petur, van Boven, Hester, Roepman, Paul, van der Kolk, Lizet E., van Houdt, Winan J., van der Graaf, Winette T.A., Meijer, Gerrit A., Voest, Emile E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773512/ https://www.ncbi.nlm.nih.gov/pubmed/35053600 http://dx.doi.org/10.3390/cancers14020436 |
Ejemplares similares
-
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)
por: Samsom, Kris G., et al.
Publicado: (2020) -
Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice
por: Samsom, Kris G, et al.
Publicado: (2022) -
Desmoid is not a sarcoma; reply to Sachdev et al.
por: van der Graaf, Winette T.A., et al.
Publicado: (2023) -
Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
por: van der Laan, Pia, et al.
Publicado: (2021) -
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
por: Schipper, L.J., et al.
Publicado: (2022)